Detalhe da pesquisa
1.
A 4-gene prognostic index for enhancing acute myeloid leukaemia survival prediction.
Br J Haematol
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651345
2.
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Blood
; 140(26): 2773-2787, 2022 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36126318
3.
Beyond The Skin: B Cells in Pemphigus Vulgaris, Tolerance and Treatment.
Br J Dermatol
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504438
4.
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia.
Br J Haematol
; 200(2): 170-174, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36263593
5.
Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma.
Int J Mol Sci
; 20(23)2019 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31801186
6.
Bone marrow necrosis as complication of treatment with all-trans retinoic acid and arsenic trioxide: case report and implications for treatment.
Ann Hematol
; 101(5): 1133-1134, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750663
7.
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.
Am J Hematol
; 97(8): E312-E317, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35702878
8.
Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.
Cancer Cell
; 12(5): 457-66, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17996649
9.
Multidimensional radar dot-plots, do we need it for the screening of acute promyelocytic leukemia?
Ann Hematol
; 98(7): 1793-1794, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31025159
10.
VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses.
Exp Hematol Oncol
; 13(1): 35, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553748
11.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leuk Lymphoma
; 65(2): 199-208, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966980
12.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine
; 71: 102553, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38533127
13.
Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance.
Cell Death Discov
; 9(1): 228, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407572
14.
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients.
Leukemia
; 37(8): 1600-1610, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349598
15.
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism.
Sci Adv
; 9(15): eadf8522, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058562
16.
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.
Blood Cancer J
; 13(1): 93, 2023 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336890
17.
10-day decitabine versus 3â+â7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.
Lancet Haematol
; 10(11): e879-e889, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914482
18.
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
Front Immunol
; 14: 1125030, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36911708
19.
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.
J Hematol Oncol
; 16(1): 32, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005697
20.
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107).
Br J Haematol
; 156(2): 205-12, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22082314